Prescription of glucagon-like peptide-1 receptor agonists by cardiologists.
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
GLP-1RAs are underused in eligible patients, particularly by cardiologists.
“Despite these findings, GLP-1RAs are underused in eligible patients, particularly by cardiologists.”
From Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review (2020) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · see citing works
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455 · see citing works
Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Cefalu, W. T., Januzzi, J. L., Kalyani, R. R., Kosiborod, M., Magwire, M. L., Morris, P. B., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.020 · Cited by 300 · see citing works
Self-citationPrescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling
Vaduganathan, M., Sathiyakumar, V., Singh, A., McCarthy, C. P., Qamar, A., Januzzi, J. L., Scirica, B. M., Butler, J., Cannon, C. P., & Bhatt, D. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2202 · Cited by 123 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Rangaswami, J., Bhalla, V., de Boer, I. H., Staruschenko, A., Sharp, J. A., Singh, R. R., Lo, K. B., Tuttle, K., Vaduganathan, M., Ventura, H., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000920 · Cited by 192 · see citing works
Self-citationAdhikari, R., Jha, K., Dardari, Z., Heyward, J., Blumenthal, R. S., Eckel, R. H., Alexander, G. C., & Blaha, M. J. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023811 · Cited by 166 · see citing works
Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
Marx, N., Davies, M. J., Grant, P. J., Mathieu, C., Petrie, J. R., Cosentino, F., & Buse, J. B. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30343-0 · Cited by 158 · see citing works
Khan, M. S., Fonarow, G. C., McGuire, D. K., Hernandez, A. F., Vaduganathan, M., Rosenstock, J., Handelsman, Y., Verma, S., Anker, S. D., McMurray, J. J. V., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045888 · Cited by 139 · see citing works
Self-citationHonigberg, M. C., Chang, L.-S., McGuire, D. K., Plutzky, J., Aroda, V. R., & Vaduganathan, M. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1966 · Cited by 127 · see citing works
Self-citationDave, C. V., Schneeweiss, S., Wexler, D. J., Brill, G., & Patorno, E. (2020) · Diabetes Care · doi:10.2337/dc19-1943 · Cited by 97 · see citing works
Tobaiqy, M. A., & Elkout, H. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01694-7 · Cited by 119 · see citing works
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF
Vaduganathan, M., Fonarow, G. C., Greene, S. J., DeVore, A. D., Kavati, A., Sikirica, S., Albert, N. M., Duffy, C. I., Hill, C. L., Patterson, J. H., et al. (2020) · JACC: Heart Failure · doi:10.1016/j.jchf.2019.12.015 · Cited by 86 · see citing works
Self-citationHamid, A., Vaduganathan, M., Oshunbade, A. A., Ayyalasomayajula, K. K., Kalogeropoulos, A. P., Lien, L. F., Shafi, T., Hall, M. E., & Butler, J. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000864 · Cited by 57 · see citing works
Self-citationKing, A., Tan, X., Dhopeshwarkar, N., Bohn, R. L., Dea, K., Leonard, C. E., & de Havenon, A. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004431 · Cited by 50 · see citing works
Beavers, K. M., Cortes, T. M., Foy, C. M., Dinkla, L., Reyes San Martin, F., Ard, J. D., Serra, M. C., & Beavers, D. P. (2025) · Obesity · doi:10.1002/oby.24172 · Cited by 41 · see citing works
Andreasen, C. R., Andersen, A., Knop, F. K., & Vilsbøll, T. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14500 · Cited by 39 · see citing works
Addressing Comorbidities in Heart Failure
Bavishi, A. A., & Patel, R. B. (2020) · Heart Failure Clinics · doi:10.1016/j.hfc.2020.06.005 · Cited by 38 · see citing works
Self-citationCardiometabolic Medicine: Development of a New Subspecialty
Saxon, D. R., Reiter–Brennan, C., Blaha, M. J., & Eckel, R. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa261 · Cited by 34 · see citing works
Implications of specialist density for diabetes care in the United States.
Patel, R. B., Al Rifai, M., McEvoy, J. W., & Vaduganathan, M. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3796 · Cited by 28 · see citing works
Ahmad, A., & Sabbour, H. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02192-4 · Cited by 25 · see citing works
Cardioprotective diabetes drugs: what cardiologists need to know
Brown, J. M., & Everett, B. M. (2019) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000181 · Cited by 24 · see citing works
Sharma, A., Aziz, H., Verma, S., Abramson, B. L., Choi, R., Chua, G. L., Connelly, K. A., Honos, G. N., Mancini, G. B. J., Ramer, S. A., et al. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000892 · Cited by 18 · see citing works
Kanumilli, N., Brunton, S., Cos, X., Deed, G., Kushner, P. R., Lin, P., & Nolte, J. E. S. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107813 · Cited by 17 · see citing works
Attitudes, Perceptions, and Practices Among Endocrinologists Managing Obesity
Agarwal, M., & Nadolsky, K. Z. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.10.006 · Cited by 17 · see citing works
Dixon, D. L., Salgado, T. M., Robinson, A., Carbone, S., Wagner, T. D., Hyder, H., Kirschner, B., Musselman, K. T., Buffington, T. M., & Sabo, R. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.08.026 · Cited by 16 · see citing works
Chang, L., Vaduganathan, M., Plutzky, J., & Aroda, V. R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1260-0 · Cited by 16 · see citing works
Self-citationRedouane, B., Greene, S. J., Fudim, M., Vaduganathan, M., Ambrosy, A. P., Sun, J., DeVore, A. D., McNulty, S. E., Mentz, R. J., Hernandez, A. F., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006758 · Cited by 15 · see citing works
Self-citationUtility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
Ge, D., Foer, D., & Cahill, K. N. (2022) · Pulmonary Therapy · doi:10.1007/s41030-022-00211-x · Cited by 14 · see citing works
Tan, X., Divino, V. M., Amamoo, J. J., Xie, L., Coyle, K. B., Gamble, C. L., Guevarra, M., Paprocki, Y., & King, A. A. (2024) · Clinical Drug Investigation · doi:10.1007/s40261-024-01354-2 · Cited by 14 · see citing works
Report from the CVOT Summit 2020: new cardiovascular and renal outcomes
Schnell, O., Cos, X., Cosentino, F., Forst, T. M., Giorgino, F., Heersprink, H. J. L., Kosiborod, M., Wanner, C., & Standl, E. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01254-1 · Cited by 13 · see citing works
Training the Next Generation of Cardiometabolic Specialists
McCarthy, C. P., Chang, L., & Vaduganathan, M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.02.017 · Cited by 13 · see citing works
Self-citationGLP-1 RAs in Spain: A Short Narrative Review of Their Use in Real Clinical Practice
Romera, I., Santos, M. R., Artola, S., Fernández, C. S., & Conget, I. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02442-z · Cited by 10 · see citing works
Newer drug treatments for type 2 diabetes
Guo, J. S., & Smith, S. M. (2021) · BMJ · doi:10.1136/bmj.n1171 · Cited by 9 · see citing works
Vaduganathan, M., Singh, A., Sharma, A., Januzzi, J. L., Scirica, B. M., Butler, J., Zannad, F. M., McGuire, D. K., Cannon, C. P., & Bhatt, D. L. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.053 · Cited by 8 · see citing works
Self-citationGLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?
Hayat, J., Shah, N. P., Agarwala, A., Khan, M. S., & Butler, J. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01214-6 · Cited by 9 · see citing works
Self-citationScheen, A. J. (2024) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2024.100197 · Cited by 7 · see citing works
McCoy, R. G., Vandergrift, J. L., & Gray, B. M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112039 · Cited by 6 · see citing works
Patel, K. V., Sarraju, A., Neeland, I. J., & McGuire, D. K. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01355-5 · Cited by 6 · see citing works
Williams, B. A., Brady, J. P., Voyce, S. J., Kumar, N., Paprocki, Y., & RAJPURA, J. R. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14686 · Cited by 5 · see citing works
Implementation of Cardiometabolic Centers and Training Programs
Taha, M. B., Rao, N., Vaduganathan, M., Cainzos‐Achirica, M., Nasir, K., & Patel, K. V. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01459-y · Cited by 5 · see citing works
Self-citationSalahuddin, T., Hebbe, A. L., Daus, M., Essien, U. R., Waldo, S. W., Rodríguez, F., Ho, P. M., Simons, C. E., Gilmartin, H., & Doll, J. A. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.11.009 · Cited by 6 · see citing works
The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice
Martens, P., Mathieu, C., & Vanassche, T. (2022) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2022.2076307 · Cited by 5 · see citing works
Kumar, S. R., Anderson, J. E., Coviello, A. D., Lopez-Jimenez, F., & Bakris, G. L. (2026) · JACC Advances · doi:10.1016/j.jacadv.2025.102465 · Cited by 4 · see citing works
Gill, G. S., Latif, A., Hilleman, D. E., Lavie, C. J., & Alla, V. M. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100878 · Cited by 3 · see citing works
Draznin, B., & Hirsch, I. B. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.12.012 · Cited by 3 · see citing works
Malas, K., Kazmi, S., Kang, Y. M., & McGuire, D. K. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2504702 · Cited by 2 · see citing works
Mai, Z., Kornak, J., Dufault, S. M., Strand, M. W., Reikes, A., & Watanabe, J. H. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251384637 · Cited by 2 · see citing works
Salahuddin, T., Richardson, V. L., McNeal, D. M., Henderson, K., Hess, P. L., Raghavan, S., Saxon, D. R., Valle, J. A., Waldo, S. W., Ho, P. M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14193 · Cited by 2 · see citing works
Alotaibi, H. F., Alnasrallah, S., Alfadda, A. A., Alquassayer, S. A., Arafat, A. A., AlMuhaidib, S., Alsayer, R. M., Alqahtani, S. A., & Alhazzani, W. A. (2025) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_672_24 · Cited by 1 · see citing works
MIN, K. H., Go, A. S., Parikh, R., Ambrosy, A. P., Tan, T. C., Adatya, S., Lee, K. K., Sandhu, A. T., Svetlichnaya, J., Vaduganathan, M., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.10.016 · Cited by 1 · see citing works
Self-citationSweeney, J., Liu, J., Warren, G. V., & Blood, A. J. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101519 · Cited by 1 · see citing works
Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic Disease
Sharma, A., Razaghizad, A., Stevens, S. R., Lokhnygina, Y. V., Bakris, G. L., Green, J. B., McGuire, D. K., Lópes, R. D., Buse, J. B., Armstrong, P. W., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102598 · Cited by 1 · see citing works
Managing Obesity in Individuals with Cardiovascular Disease: Are We Missing the Obvious?
Gao, M., Kurala, T. S., & Ajjan, R. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.53 · Cited by 1 · see citing works
Why Are Cardiologists Not Prescribing the New Diabetes Medications?
Klein, L. W. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.10.040 · Cited by 1 · see citing works
Editorial commentary: How to build an actionable narrative for cardio-oncology
Nolan, M. T., Ngo, D. T. M., & Sverdlov, A. L. (2024) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2024.06.001
Ahmad, A., & Sabbour, H. M. (2024) · Figshare · doi:10.6084/m9.figshare.26695041
Ahmad, A., & Sabbour, H. M. (2024) · Figshare · doi:10.6084/m9.figshare.26695038
Dixon, D. L., Salgado, T. M., Robinson, A., Carbone, S., Wagner, T. D., Hyder, H., Kirschner, B., Musselman, K. T., Buffington, T. M., & Sabo, R. (2026) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2026.103106
Salgado, T. M., Amayreh, R., Alshahawey, M., Musselman, K. T., Buffington, T. M., Hyder, H., Jones, R. M., & Dixon, D. L. (2026) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70263
- Authors
- Vaduganathan, M., Patel, R. B., Singh, A., McCarthy, C. P., Qamar, A., Januzzi, J. L., Scirica, B. M., Butler, J., Cannon, C. P., & Bhatt, D. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Bhatt, Deepak L.
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 73
- Issue
- 12
- Pages
- 1596-1598
- ISSN
- 0735-1097 (ISSN-L)
- PMC
- PMC6764415
- OpenAlex
- W2923192703
- Cited by
- 55
- References
- 4
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 2 · 2022: 6 · 2021: 7 · 2020: 15 · 2019: 3
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Heart Association (18SFRN3390085, T32 HL007604)
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Bayer (T32HL007604)
- GlaxoSmithKline
- Sanofi
- Brigham and Women's Hospital
- Biogen
- Alnylam Pharmaceuticals
- Harvard Catalyst (UL1TR002541, 1TR002541)
- Cleveland Clinic
- Boston Scientific Corporation
- Boston VA Research Institute
- Regeneron Pharmaceuticals
- Ironwood Pharmaceuticals, Incorporated
- Amarin Corporation
- Medicines Company
- Kowa Company
- Luitpold Pharmaceuticals
- Singulex
- Regado Biosciences
- Belvoir Media Group
- European Commission
- Daiichi-Sankyo
- Eisai
- Novo Nordisk
- Vifor Pharma
- Idorsia Pharmaceuticals
- National Institutes of Health (UL1TR002541, 1TR002541, UL1TR001863)
- St. Jude Medical (UL 1TR002541)
- Relypsa
- National Heart, Lung, and Blood Institute (T32HL069771, T32HL007604)
- National Center for Advancing Translational Sciences (1TR002541)
- Duke Clinical Research Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- GLP-1 receptor agonists, prescribing patterns, cardiologists, type 2 diabetes, glycemic control
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Cardiologists, Glucagon-Like Peptide-1 Receptor Agonists, Cardiovascular Agents, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Drug Utilization, Female, Humans, Hypoglycemic Agents, Male, Middle Aged, Practice Patterns, Physicians', United States, United States Food and Drug Administration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
